从算法到生物标志物：迈向静脉血栓栓塞的个性化管理
From Algorithms to Biomarkers: Toward Personalized Management of Venous Thromboembolism.
作者信息
Boccatonda Andrea
机构信息
Diagnostic and Therapeutic Interventional Ultrasound Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
出版信息
J Clin Med. 2025 Sep 1;14(17):6172. doi: 10.3390/jcm14176172.
Abstract
Pulmonary embolism (PE) and venous thromboembolism (VTE) remain major contributors to global morbidity and mortality, yet their management has evolved significantly in recent years [...].
摘要
肺栓塞（PE）和静脉血栓栓塞症（VTE）仍然是全球发病率和死亡率的主要原因，然而近年来它们的治疗方法已经有了显著的发展[...]。
相似文献
1
From Algorithms to Biomarkers: Toward Personalized Management of Venous Thromboembolism.从算法到生物标志物：迈向静脉血栓栓塞的个性化管理
J Clin Med. 2025 Sep 1;14(17):6172. doi: 10.3390/jcm14176172.
2
Trends of hospital admissions due to acute limb ischemia and venous thromboembolism in Austria: A population-wide observational analysis from 2009 to 2023.
Thromb Res. 2025 Jul;251:109337. doi: 10.1016/j.thromres.2025.109337. Epub 2025 May 8.
3
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.药物干预预防接受减重手术人群的静脉血栓栓塞症。
Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2.
4
Pentasaccharides for the prevention of venous thromboembolism.用于预防静脉血栓栓塞的五糖
Cochrane Database Syst Rev. 2016 Oct 31;10(10):CD005134. doi: 10.1002/14651858.CD005134.pub3.
5
Smart Technology Facilitated Patient-Centered Venous Thromboembolism Management (the SmaVTE Study): Protocol for a Randomized Controlled Trial.智能技术辅助的以患者为中心的静脉血栓栓塞管理（SmaVTE研究）：一项随机对照试验的方案
JMIR Res Protoc. 2025 Jun 5;14:e67254. doi: 10.2196/67254.
6
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.对无诱因静脉血栓栓塞症（VTE）患者进行癌症检测对癌症及VTE相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD010837. doi: 10.1002/14651858.CD010837.pub3.
7
Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in patients with unprovoked VTE.对无诱因静脉血栓栓塞症（VTE）患者进行癌症检测对癌症及VTE相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2015 Mar 6(3):CD010837. doi: 10.1002/14651858.CD010837.pub2.
8
Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.不明原因静脉血栓栓塞症（VTE）患者中，检测癌症对癌症或静脉血栓栓塞症（VTE）相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2021 Oct 1;10(10):CD010837. doi: 10.1002/14651858.CD010837.pub5.
9
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients.联合间歇性气动腿部压迫与药物预防以预防高危患者静脉血栓栓塞症
Cochrane Database Syst Rev. 2008 Oct 8(4):CD005258. doi: 10.1002/14651858.CD005258.pub2.
10
Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.采用混合治疗比较的荟萃分析方法评估口服抗凝剂用于静脉血栓栓塞症的长期治疗。
Clin Ther. 2014 Oct 1;36(10):1454-64.e3. doi: 10.1016/j.clinthera.2014.06.033. Epub 2014 Aug 3.
本文引用的文献
1
Implications of the API-CAT Trial for Extended Secondary Prophylaxis of Cancer-associated Venous Thromboembolism: Guidance from an Expert Panel.
Hamostaseologie. 2025 Aug 7. doi: 10.1055/a-2645-4927.
2
Thrombotic events after vaccination for covid-19 in Italy: a report from the Italian society on thrombosis and haemostasis registry.意大利新冠疫苗接种后的血栓形成事件：来自意大利血栓形成与止血学会登记处的报告
Intern Emerg Med. 2025 Jul 30. doi: 10.1007/s11739-025-04054-7.
3
Efficacy and safety of anticoagulant treatment in elderly patients with venous thromboembolism beyond the first 3 to 6 months of therapy: A narrative review.
Thromb Res. 2025 Sep;253:109403. doi: 10.1016/j.thromres.2025.109403. Epub 2025 Jul 14.
4
Variability in Inferior Vena Cava (IVC) Filter Retrieval Rates and Adherence to Guidelines: A Multi-Center Retrospective Analysis.下腔静脉（IVC）滤器取出率的变异性及对指南的遵循情况：一项多中心回顾性分析
J Clin Med. 2025 Jun 7;14(12):4034. doi: 10.3390/jcm14124034.
5
Internal Jugular Vein Thrombosis: A Bicentric Cohort Study.颈内静脉血栓形成：一项双中心队列研究。
J Clin Med. 2025 May 22;14(11):3626. doi: 10.3390/jcm14113626.
6
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.延长低剂量阿哌沙班用于癌症相关静脉血栓栓塞症
N Engl J Med. 2025 Apr 10;392(14):1363-1373. doi: 10.1056/NEJMoa2416112. Epub 2025 Mar 29.
7
The Prevalence of Previous Coronavirus Disease-19 in Patients with Pulmonary Thromboembolism and Its Effect on Embolism Severity.肺血栓栓塞症患者中既往冠状病毒病-19的患病率及其对栓塞严重程度的影响。
J Clin Med. 2025 Mar 12;14(6):1909. doi: 10.3390/jcm14061909.
8
Characteristics and Outcomes of Pulmonary Embolism Patients Transferred After Activation of Pulmonary Embolism Response Team and Admitted from Local Emergency Department.肺栓塞反应团队启动后转诊并从当地急诊科收治的肺栓塞患者的特征与结局
J Clin Med. 2025 Jan 22;14(3):677. doi: 10.3390/jcm14030677.
9
From Cell Interactions to Bedside Practice: Complete Blood Count-Derived Biomarkers with Diagnostic and Prognostic Potential in Venous Thromboembolism.从细胞相互作用到临床实践：全血细胞计数衍生的生物标志物在静脉血栓栓塞症中的诊断和预后潜力
J Clin Med. 2025 Jan 2;14(1):205. doi: 10.3390/jcm14010205.
10
Rationale and design of the PE-TRACT trial: A multicenter randomized trial to evaluate catheter-directed therapy for the treatment of intermediate-risk pulmonary embolism.PE-TRACT试验的原理与设计：一项多中心随机试验，旨在评估导管导向治疗对中度风险肺栓塞的治疗效果。
Am Heart J. 2025 Mar;281:112-122. doi: 10.1016/j.ahj.2024.11.016. Epub 2024 Dec 3.
Zotero 插件